REGISTER FOR THE EVENT<\/span><\/strong><\/a><\/p>\nOctober 24th<\/sup>-25th<\/sup>, 2019, \u201cOpal\u201dHall, Hotel \u201cRamada\u201d, Sofia<\/strong><\/p>\nOrganized by the Bulgarian Alliance for Precision and Personalized Medicine \u2013 BAPPM<\/p>\n
In collaboration with the European Alliance for Personalised Medicine \u2013 EAPM, Medical University Pleven and Bulgarian Society of Human Genetics and Genomics<\/p>\n
Program<\/strong><\/h2>\nThursday, October 24th<\/sup>, 2019<\/h3>\n13.30 \u2013 14.00 Registration<\/strong><\/p>\n14.00 \u2013 14.30 Opening: Setting the Scene<\/strong><\/p>\nDr. Jasmina Koeva, Chair of the Board, BAPPM<\/strong><\/p>\nDenis Horgan, Executive Director EAPM<\/strong><\/p>\nKeynote opening speech: Maria Gabriel \u2013 European Commissioner for Digital Economy and Society<\/strong><\/p>\nDiscussion with European Commissioner<\/em><\/strong><\/p>\n14.30 \u2013 16.00 First Plenary <\/strong>Ses<\/strong>sion: Forward Together in the <\/strong>Personalised Medicine Era<\/strong><\/p>\nPersonalized Medicine \u2013 What will be covered in this opening session is the broad impact of the personalized medicine, which promises to create a new paradigm in healthcare.<\/p>\n
The key is to find the optimum ways by which to integration personalized medicine into the EU\u2019s healthcare systems, facilitate, the introduction of innovative pharmaceuticals and diagnostics, and build the necessary legal and regulatory frames.<\/p>\n
In addition, there is a need to formulate optimal HTA of personalized medicine products, and, of course, bring about the best pathways to dramatically improve patient access to innovative treatments<\/p>\n
Chair of session and Scene Setting: Denis Horgan, Executive Director EAPM<\/strong><\/p>\nKarina Angelieva \u2013 Deputy Minister of Education and Science, Bulgaria:”Bulgaria on the European Map of Personalised Medicine – BBMRI, EATRIS, Centers of Excellence and Centres of Competence, National Research Programme”\u00a0<\/em><\/strong><\/p>\nDr. Tuula Helander<\/strong> –\u00a0Finnish Presidency of European Council, Ministry of Social Affairs and Health, Finland:”Personalised medicine and national centers of excellence in public health”<\/em><\/strong><\/p>\nAss. prof. dr. Lachezar Ivanov \u2013 Vice-chair of Health Commission in the Parliament of Bulgaria\u00a0<\/strong><\/p>\nDr. Jana Makedonska, Policy Officer, Unit for Health Innovations, DG Research & Innovation, European Commission:<\/strong> \u201cEuropean support for international cooperation in personalised medicine\u201d<\/em><\/strong><\/p>\nQ&A<\/strong><\/p>\n16.00 \u2013 17.40 Second Plenary Session:\u00a0 Genomics for Healthcare<\/strong><\/p>\nThis session will look at new achievements in human genomics and genetics alongside gene therapy and the European Genomic Initiative \u201c1+MG\u201d.<\/p>\n
With rising healthcare costs and systems being increasingly challenged, genomics has the potential to impact the health of all of us and provide diagnostic, economic and efficiency benefits, ensuring a patient has the right information, to get the right treatment, at the right time.<\/p>\n
The potential for bettering the health of citizens across all Member States is huge.<\/p>\n
If fully realized genomics will have a positive impact on the health of all of us by giving diagnostic, economic and efficiency benefits by ensuring the right patient, gets the right diagnosis and treatment, at the right time. Also hugely important for healthcare (and fiscal) reasons is the preventative sector which involves screening and early diagnosis, while the session will also include the important areas of rare diseases, oncology and neurological diseases.<\/p>\n
Precision diagnostics are vital today, so we will look at NGS in preventive medicine and clinical practice. Comprehensive genomic profiling will also be discussed.<\/p>\n
On top of this, the growing area of AI in personalized medicine cannot be denied, but implementing it is a key. Here we look at the current status and future possibilities.<\/p>\n
Session chair: Prof. Dr. Draga Toncheva \u2013 President of Bulgarian Scientific Society for Human Genomics and Genetics <\/strong><\/p>\nSetting the Scene: Dr. Jasmina Koeva-Balabanova, Chair of BAPPM: \u201c1+ MG\u201dInitiative<\/em><\/strong><\/p>\nProf. Dr. Borut Peterlin, <\/strong>Head of the Clinical Institute of Medical Genetics, Ljubljana, Slovenia:\u00a0<\/strong> \u201c<\/em><\/strong>Public health genomics: lessons from rare diseases\u201d<\/em><\/strong><\/p>\nDr. Radoslav Mangaldjiev \u2013 Chair of Society of Medical Oncologists, Specialized Hospital for Active Treatment in Oncology, Sofia, Bulgaria: \u201cThe Advantage of Foundation Medicine-Comprehensive Genomic Profiling in clinical Practice\u201d<\/em><\/strong><\/p>\n\u00a0<\/strong>Hari Radhakrishnan, Chief Business Development Officer at NIPD Genetics<\/strong>, Cyprus:<\/strong> \u201cNext-generation oncology panels for detailed analysis of cancer <\/em><\/strong>genes\u201d<\/em><\/strong><\/p>\nProf. Dr. Draga Toncheva, President of Bulgarian Scientific Society for Human Genomics and Genetics: \u201c<\/em>Medical genetic counseling and risk assessment for hereditary prostate cancer\u201d<\/em><\/strong><\/p>\nQ&A<\/strong><\/p>\n17.40 \u2013 18.00 Coffee-break<\/p>\n
18.00 \u2013 19.10 Third Plenary Session:\u00a0 The pathology of Personalised Medicine<\/strong><\/p>\nMolecular pathology \u2013 specifically new achievements and implementation in clinical practice.<\/p>\n
Precision imaging in modern-day healthcare.<\/p>\n
Session chair: Prof. dr. Savelina Popovska \u2013 Vice-rector Medical University Pleven, Bulgaria<\/strong><\/p>\nProf. Dr. George J Netto, Chair of Department of Clinical Pathology, University of Alabama at Birmingham, USA: <\/em><\/strong>\u00a0“Molecular Pathology – opportunities and challenges”\u00a0<\/em><\/strong><\/p>\nProf. Sven Seiwerth \u2013 Head of Department of Pathology, University of Zagreb, Croatia<\/strong>: <\/strong>\u201cPredictive biomarker testing in Croatia<\/em><\/strong>\u201c<\/em><\/strong><\/p>\nProf. Dr. Sonya Sergieva-Chief of Department \u201cNuclear Medicine\u201d, Specialized Hospital in Active Treatment in Oncology, Sofia, Bulgaria:<\/strong> \u201cTeranostica \u2013\u00a0 current nuclear medicine diagnostic and therapeutic approach for personalized \u00a0 treatment of neuroendocrine tumors<\/em><\/strong>\u201c<\/em><\/strong><\/p>\nQ&A<\/strong><\/p>\n19.30 \u2013 22.00<\/strong> Official Dinner and announcement of the winners of BAPPM Awards for Personalized Medicine in Bulgaria<\/strong><\/p>\nHost: Dr. Jasmina Koeva-Balabanova, Chair of the Board of BAPPM<\/p>\n